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Abstract 
 
A 47-year-old lady, presented with progressive proptosis of left eye with deterioration of vision. She had a history of 
left solitary fibrous tumour and had undergone left frontal craniotomy and orbitotomy in 2004. Surveillance 
Magnetic resonance imaging (MRI) six years later showed tumour recurrence with intracranial extension. However, 
she did not follow-up and only presented again 3 years, later. Tumour resection and left exenteration was performed. 
Histology showed ‘patternless’ pattern of neoplastic cells, and CD34 staining was diffusely positive. Diagnosis of 
recurrent solitary fibrous tumour with intracranial extension was made. 
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Introduction 
 
Solitary fibrous tumour (SFT) is a rare spindle-shaped 
neoplasm which was initially believed to be arising 
from mesothelium. Classically, it was localised in the 
pleura (1). Extrathoracic SFT can be found in the skin, 
paranasal sinuses, orbit and other sites. Generally, the 
SFT is a benign tumour with indolent behavior and 
malignant transformation is uncommon. Previously, 
SFT of orbit was rarely diagnosed but with presence of 
CD34 staining, the diagnosis of SFT becomes more 
common. Here, we report a case of recurrent SFT with 
intracranial extension. 
 
Case Report 
 
A 47-year-old Chinese lady presented with painless and 
rapidly progressive left eye proptosis associated with 
blurring of vision of 2 months duration. She denied any 
diplopia, or history of recent trauma. Her family 
members noticed she had behavioral changes and 
insomnia. However, there were no symptoms of 
increased intracranial pressure or constitutional 
symptoms. She had a history of left orbitotomy and 
craniotomy with excision of tumour for an intraconal 
tumour 9 years ago. Intraoperatively, the tumour was 
excised, however parts of the tumour that were adherent 
to levator palpebrae superioris and medial rectus were 
diathermised. Histology confirmed the diagnosis of 
solitary fibrous tumour and immunohistochemical 
studies showed positivity towards CD34. She was well 
until recurrence of tumour was detected 6 years post-
surgery during tumour surveillance. Magnetic resonance 
imaging (MRI) revealed an intraconal mass in the 
medial part of retro-orbital region, measuring 2.2 cm x 2 
cm x 2.5cm with evidence of optic nerve compression 
by the tumour. However, patient defaulted her follow-
up as she sought for traditional treatment. She only 
presented again with the current symptoms 3 years later.   
 
Left visual acuity was 1/60, with presence of left 
relative afferent pupillary defect (RAPD). External  
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Figure 1: MRI of orbit and brain show T2 weighted image 
of large extraconal mass pushing the globe inferotemporally 
and it breaches the cribriform plate to extend intracranially 
into both frontal lobes. 
 
examination showed a left non-axial proptosis, with 
restriction of extraocular muscles movements in all 
directions. The proptosis was 8mm on Hertel 
measurements, and retropulsion test was positive. 
Intraocular pressure was normal. Left optic disc was 
swollen with tortuosity of vessels. Right eye showed 
normal findings. Optic nerve function tests showed the 
left optic nerve was compromised.   
 
MRI of brain and orbit showed heterogenous 
enhancing extraconal mass at medial aspect of the orbit 
measuring 5.6 cm x 5.1 cm x 6.0 cm, exhibiting mixed 
heterogenous signal intensity on T1 and T2 weighted 
images with multiseptations and cystic components 
within. There was clear demarcation between the mass 
and the left globe, but no clear fat demarcation between 
the mass and medial rectus, inferior rectus, superior 
rectus, superior oblique and left lacrimal gland, 
suggestive of infiltration. The lateral rectus was spared. 
The left optic nerve was infiltrated by the mass. The 
mass breached the left lamina papyracea to extend into 
the ethmoidal sinus, crossing the midline to compress 
onto contralateral intracanalicular segment of the right 
optic nerve. The mass breached the cribriform plate and 
extend intracranially into both frontal lobes resulting in 
mass effect. 
 
The tumour was accessed via bifrontal craniotomy. 
Tumour excision and left exenteration was done. 
Intraoperatively, the recti muscles and lacrimal gland 
were enlarged. The tumour was believed to be 
originating from the medial side of the globe, likely 
from the medial rectus, encasing the optic nerve.  
 
Histopathological examination showed a tumour 
composed of ‘patternless’ pattern of neoplastic cells  
 
 
Figure 2: a) H&E (4x) stain shows branching vessels in 
solitary fibrous tumour (arrow), positivity towards b) CD34 
c) CD99 d) BCL-2. 
 
 
exhibiting bland spindle to ovoid nuclei and faintly 
eosinophilic cytoplasm, with presence of hyalinised 
collagen in between the neoplastic cells. There was 
local infiltration of malignant cells into extraocular 
muscle bundles and involvement of posterior margin. 
Immunohistochemical staining showed positivity for 
CD34, CD99, Vimentin and focally positive for SMA 
and BCL-2. The staining was negative for EMA, 
desmin, CK, CD31 and S100.  
 
Post-operatively, the patient was assessed by oncology 
team however there was no role of radiotherapy. 
Yearly surveillance MRIs did not show any residual 
and recurrence of the tumour. She is not on any 
prosthesis. She is currently well, being employed and 
happy with her life. 
 
Discussion 
 
Solitary fibrous tumour is an indolent benign neoplasm 
that affects mainly middle-aged adults. In 1931, 
Klemper and Rabin described it as 'localised 
mesothelioma', which classically occurs in the pleura 
(1). SFT of orbit was first described in 1994 by Westra 
et al. in presence of strong and generalized 
immunohistochemistry staining with CD34 (2).  
 
Despite SFT being a histological diagnosis, 
radioimaging plays an important role in diagnosing 
SFT. Magnetic resonance imaging (MRI) of SFT 
showed T1 signal intensity that is isointense to gray 
matter with heterogenous gadolinium enhancement 
(3). Low T2 signal indicate presence of calcification or 
a fibrous lesion. In SFT, T2 image shows hypointense 
to gray matter due to lack of local water density in 
collagenous stroma in SFT5. However, in our patient 
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MRI showed heterogenous signal intensity in both T1 
and T2 weighted images. The heterogeneity is 
believed to be due to presence of fibrous stroma 
intermixed with the prominent vessels (4).  
 
SFT should be differentiated from other soft tissue 
tumour such as angiomatoid fibrous histiocytoma 
(AFH) as they share similar histological features. 
Histological features of SFT show presence of 
branching hemangiopericytoma-like vessels, while in 
AFH the blood vessels arrangement is well-formed. 
With advances in immunohistochemical staining, SFT 
can be distinguished from AFH. SFT shows diffuse 
staining with CD34 while AFH shows negative 
staining towards CD34 (5). 95% of cases of SFT 
express CD34. About 70% cases with SFT showed 
positivity with CD99 and 20-30% with EMA (6). Bcl-
2 is non-specific, as it is also seen in other 
mesenchymal neoplasms. SFT shows negative staining 
with S100, Cytokeratin, EMA, SMA and desmin. 
Strong positivity of CD34 also indicate benign nature 
of SFT, as compared in malignant transformation of 
SFT, the tumour has high mitotic rate with atypia and 
loss its CD34 immunoreactivity (7).  
 
Incomplete resection of tumour is the most important 
predictor for local recurrence. Alexandrakis and 
Johnson reported a case of incomplete excision of SFT 
in 14-year-old girl lead to recurrence (8). We believe 
that our patient developed recurrence due to inability 
to excise the adherent part of the tumour bulk at initial 
resection. Patient was at risk of developing post-
operative diplopia which might affect patient’s quality 
of vision in attempt to excise the adherent part of the 
tumour. However, metastases in SFT has not yet been 
reported. 
 
Intracranial extension is uncommon; however the 
tumour can breach the lamina papyracea to infiltrate 
into frontal lobes or via the bony foramina of the orbit. 
There were 3 cases of SFT with intracranial extension 
reported previously, in which all of the three cases 
recurred due to incomplete excision of the tumours 
(9,10,11). 
 
In conclusion, the advances in immunohistochemical 
staining assist in establishing the diagnosis of SFT and 
differentiating it from other tumours. Total resection 
of the tumour is important to prevent recurrence.   
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